Cost-effectiveness of salmeterol/fluticasone propionate combination product 50/250 μ g twice daily and budesonide 800 μ g twice daily in the treatment of adults and adolescents with asthma
- 31 July 2000
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 94 (7), 724-732
- https://doi.org/10.1053/rmed.2000.0876
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Salmeterol/fluticasone propionate combination therapy 50/250 μ g twice daily is more effective than budesonide 800 μ g twice daily in treating moderate to severe asthmaRespiratory Medicine, 2000
- The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthmaAnnals of Allergy, Asthma & Immunology, 1999
- Efficacy of Salmeterol Xinafoate Powder in Children with Chronic Persistent AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Fluticasone propionate 50 μg BID versus 100 μg BID in the treatment of children with persistent asthmaClinical Therapeutics, 1998
- Efficacy, Safety, and Effects on Quality of Life of Salmeterol Versus Albuterol in Patients with Mild to Moderate Persistent AsthmaAnnals of Allergy, Asthma & Immunology, 1998
- Effect of Inhaled Formoterol and Budesonide on Exacerbations of AsthmaNew England Journal of Medicine, 1997
- Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroidThe Lancet, 1994
- The Episode-Free Day as a Composite Measure of EffectivenessPharmacoEconomics, 1993
- Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.Archives of Disease in Childhood, 1993
- Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.Thorax, 1993